Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ESOMEPRAZOLE STRONTIUM | Belcher Pharmatech | N-202342 DISCN | 2013-08-06 | 2 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
acid reducer | ANDA | 2023-10-25 |
basic care esomeprazole magnesium | ANDA | 2020-08-19 |
berkley and jensen heartburn treatment | ANDA | 2020-01-29 |
careone esomeprazole magnesium | ANDA | 2019-12-18 |
dg health esomeprazole magnesium | ANDA | 2021-12-09 |
esomeprazole | ANDA | 2023-11-03 |
esomeprazole dr | ANDA | 2023-08-23 |
esomeprazole magnesium | ANDA | 2024-01-18 |
esomeprazole magnesium delayed-release capsules, 20 mg | ANDA | 2023-10-03 |
esomeprazole sodium | ANDA | 2023-10-26 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 8 | 17 | 23 | 33 | 19 | 97 |
Infections | D007239 | EFO_0000544 | — | 1 | 1 | 3 | 43 | 21 | 69 |
Healthy volunteers/patients | — | — | — | 43 | 1 | 1 | 6 | 1 | 51 |
Dyspepsia | D004415 | EFO_0008533 | K30 | 3 | 6 | 4 | 11 | 1 | 23 |
Stomach ulcer | D013276 | — | K25 | 1 | — | 13 | 2 | 5 | 21 |
Gastritis | D005756 | EFO_0000217 | K29.7 | 2 | 1 | 3 | 8 | 4 | 18 |
Peptic ulcer | D010437 | HP_0004398 | K27 | 3 | 1 | 2 | 9 | 1 | 16 |
Esophagitis | D004941 | HP_0100633 | K20 | 1 | 2 | 7 | 5 | 1 | 16 |
Heartburn | D006356 | — | R12 | 1 | 1 | 3 | 7 | 1 | 12 |
Peptic esophagitis | D004942 | EFO_1001095 | — | 1 | 2 | 4 | 2 | 2 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Duodenal ulcer | D004381 | EFO_0004607 | K26 | 1 | — | 4 | — | 5 | 10 |
Arthritis | D001168 | HP_0001369 | M05-M14 | 4 | — | 2 | — | — | 6 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | 1 | 2 | — | 2 | 5 |
Gastrointestinal diseases | D005767 | — | — | 1 | — | 2 | — | 2 | 5 |
Non-erosive reflux disease | D000096663 | — | — | — | 1 | 1 | — | 2 | 4 |
Asthma | D001249 | EFO_0000270 | J45 | — | 2 | 1 | — | — | 3 |
Gastrointestinal hemorrhage | D006471 | HP_0002239 | K92.2 | — | 1 | 2 | — | — | 3 |
Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | — | 1 | 1 | — | 1 | 2 |
Esophageal neoplasms | D004938 | — | C15 | — | 1 | 1 | — | — | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 2 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 1 | 1 | — | — | — | 2 |
Replacement arthroplasty knee | D019645 | — | — | — | 1 | — | — | — | 1 |
Neuralgia | D009437 | EFO_0009430 | — | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Heart valve diseases | D006349 | EFO_0009551 | I08 | — | 1 | — | — | — | 1 |
Autistic disorder | D001321 | HP_0000717 | F84.0 | — | 1 | — | — | — | 1 |
Deglutition disorders | D003680 | HP_0002015 | R13.1 | — | 1 | — | — | — | 1 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 1 | — | — | — | 1 |
Gram-negative bacterial infections | D016905 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 4 | — | — | — | 1 | 5 |
Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | — | — | — | — | 1 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 1 | — | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
Homeostasis | D006706 | — | — | 1 | — | — | — | — | 1 |
Chronic pancreatitis | D050500 | EFO_0000342 | K86.1 | 1 | — | — | — | — | 1 |
Achlorhydria | D000126 | — | K31.83 | 1 | — | — | — | — | 1 |
Hot flashes | D019584 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 2 | 2 |
Drug interactions | D004347 | — | — | — | — | — | — | 1 | 1 |
Pyloromyotomy | D000074882 | — | — | — | — | — | — | 1 | 1 |
Calcium metabolism disorders | D002128 | EFO_0005769 | E83.5 | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Radiotherapy | D011878 | — | — | — | — | — | — | 1 | 1 |
Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 1 | 1 |
Hemostasis | D006487 | — | — | — | — | — | — | 1 | 1 |
Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | — | — | 1 | 1 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | — | — | — | — | 1 | 1 |
Drug common name | Esomeprazole strontium |
INN | esomeprazole |
Description | Nexium Control (esomeprazole strontium) is a small molecule pharmaceutical. Esomeprazole strontium was first approved as Esomeprazole strontium on 2013-08-06. It is used to treat duodenal ulcer, esophagitis, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. It has been approved in Europe to treat gastroesophageal reflux. |
Classification | Small molecule |
Drug class | antiulcer agents (benzimidazole derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.O.O.O.O.[Sr+2] |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2146140 |
ChEBI ID | — |
PubChem CID | 16048656 |
DrugBank | — |
UNII ID | N3PA6559FT (ChemIDplus, GSRS) |